REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a Silicon Valley surgical robotics company developing intelligent solutions to transform the field of urology, today announced ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics, a Silicon Valley surgical robotics company developing novel and disruptive technologies to treat prostate disease, announced that the U.S.
The FDA has granted a de novo request for Procept Biorobotics Inc.'s Aquabeam system for the resection and removal of prostate tissue for the treatment of lower urinary tract symptoms (LUTS) as a ...
EVANSTON, Ill., Aug. 16, 2023 (GLOBE NEWSWIRE) -- NorthShore University HealthSystem (NorthShore) and PROCEPT BioRobotics ® announce a significant milestone in access to treatment of Benign Prostatic ...
Delray Medical Center is the first hospital in Palm Beach and Broward Counties to offer the AquaBeam Robotic System Aquablation therapy for treatment of lower urinary tract symptoms (LUTS) and benign ...
On Monday, Piper Sandler, a financial services firm, increased its price target for Procept BioRobotics Corp (NASDAQ:PRCT) shares to $75.00, up from the previous target of $67.00. The firm also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results